脑星形细胞肿瘤多体素1H-MRS代谢物含量变化及其与Ki-67的相关性

目的:探讨脑星形细胞肿瘤中多体素1H-MRS代谢物含量的变化及其与Ki-67间的相关性。方法:应用SiemensSonata 1.5T超导型MR成像系统对41例脑星形细胞肿瘤患者进行常规MR扫描及MRS检查,其中28例进行了Ki-67抗原指标的免疫组化染色。磁共振波谱分析采用四通道正交头部专用线圈3D-CSI序列扫描,比较分析不同级别星形细胞肿瘤间代谢物情况。用兔抗人Ki-67单克隆抗体测定肿瘤标本的Ki-67抗原标记指数。应用SPSS统计软件进行统计学相关性分析。结果:低级别组脑星形细胞肿瘤多体素?1H-MRS均表现为Cho峰不同程度增高和NAA峰不同程度的降低,5例出现Lac峰,无出现Lip峰。高级别组脑星形细胞肿瘤均表现为Cho峰明显增高,NAA不同程度的明显降低,21例出现Lac峰,11例出现Lip峰。高低级别肿瘤间Cho/Cr,Cho/NAA和Lac/Cr比值有统计学意义的差别。Cho/Cr、Cho/NAA比值与Ki-67指数间均存在明显的相关关系(其相关系数分别为0.640、0.694)。结论:多体素1H-MRS代谢物含量与Ki-67间有良好的相关性,磁共振波谱分析能够为星形细胞肿瘤治疗方案的制定提供更多信息。     

~1H-MRS及DTI在颅内肿瘤诊断及手术中应用的初步研究

目的:探讨质子磁共振波谱分析(~1H-MRS)对颅内肿瘤对脑肿瘤诊断价值,同时利用弥散张量成像(DTI)观察皮质脊髓束的累及情况,评价颅内肿瘤预后中的价值.方法:选取40例颅内肿瘤患者,于手术前进行~1H-MRS及DTI,并与术后病理结果进行对照,根据肿瘤内多种代谢产物水平对颅内肿瘤进行分型及胶质瘤恶性程度分级的能力,并行三维白质纤维重建,分析病灶侧白质纤维束的改变情况并观察手术前后肌力恢复情况.结果:星形细胞瘤25例,NAA减少到对侧正常组织的40%～70%,Cr明显下降与正常各半,比较Ⅰ～Ⅱ级与Ⅲ～Ⅳ级星形细胞瘤其肿瘤内代谢化合物NAA/Cr、NAA/Cho和Cho/Cr比值差异有统计学意义(P<0.05);转移瘤5例、脑膜瘤10例有NAA峰但明显低于星形细胞瘤,转移瘤及脑膜瘤NAA/Cho和NAA/Cr比值明显低于星形细胞瘤(P<0.05),转移瘤与脑膜瘤Cr低或缺乏,5例转移瘤都出现Lipid峰,3例出现Lac峰.星形细胞瘤、脑膜瘤、转移瘤Cho峰均显著增高,但脑膜瘤Cho显著升高更明显,其Cbo/Cr显著升高.皮质脊髓束表现为无受压中断、受压无中断及中断、破坏,其受累侧肢体肌力术后表现无明显减退、治疗后肌力恢复、治疗后肌力无恢复.结论:颅内肿瘤采用~1H-MRS的Cho/Cr、NAA/Cr、Lac/Cr、Lipid/Cr代谢物比值结合常规MRI对颅内肿瘤诊断及对胶质瘤进行无创性分级是可行的,DTI能够较直观地反映肿瘤对皮质脊髓束的影响情况,为判断手术后疗效提供重要预测依据.     

MR-Perfusions- und spektroskopische Bildgebung bei WHO-Grad-II-Astrozytomen

BACKGROUND: This study evaluates whether MR perfusion imaging and spectroscopic imaging (MRSI) can depict anaplastic areas in WHO grade II astrocytomas, whether these areas are co-localized, and whether the prognosis can be better predicted. MATERIAL AND METHODS: Fifteen patients (nine female, six male, aged 42+/-14 years) with WHO grade II astrocytomas but without preceding radio- or chemotherapy were examined every 3 months with MR perfusion imaging and MRSI (mean follow-up 18 months). Using a region of interest analysis, the regional relative cerebral blood volume (rrCBV) and blood flow (rrCBF) were measured in tumor tissue. In the same areas, choline/creatine (Cho/Cr) and choline/N-acetyl-aspartate (Cho/NAA) ratios were quantified. RESULTS: During follow-up, nine patients had stable disease. In six patients, the tumor showed progression and contrast-enhancement. The progressing tumors had already had higher perfusion (rrCBF 2.1+/-1.4; rrCBV 1.9+/-1.1) parameters than the stable astrocytomas (rrCBF 1.2+/-0.6, p=0.01; rrCBV 1.4+/-0.8, p=0.05) at first examination. However, the Cho/NAA and Cho/Cr ratios only tended to be higher than in stable astrocytomas (Cho/NAA 2.4+/-1.0 vs. 2.0+/-1.5, p=0.23; Cho/Cr 1.7+/-0.6 vs. 1.4+/-0.5, p=0.06). In all six progressing tumors, areas of maximum perfusion and maximum Cho/NAA and Cho/Cr ratio were co-localized. During follow-up, contrast-enhancement was observed in these areas. CONCLUSIONS: MR perfusion imaging can depict anaplastic areas in WHO grade II astrocytomas earlier than conventional MRI and thus enables a better prediction of prognosis.     

3.0T ~1H-MRS在脑内高级别星形细胞瘤及单发转移瘤鉴别诊断中的价值

目的:探讨多体素氢质子磁共振波谱(1 H-MRS)对脑高级别星形细胞瘤、单发脑转移瘤的鉴别诊断价值。方法:收集经手术、活检病理证实的颅脑肿瘤患者37例,其中高级别星形细胞瘤(Ⅲ~Ⅳ级)17例(间变性星形细胞瘤5例,胶质母细胞瘤12例),脑单发转移瘤20例。37例行颅脑常规MRI检查及多体素1 H-MRS分析,分析肿瘤实质强化区、强化边缘区、对侧相应正常区域脑组织的生化代谢物及其比值,并进行对照。结果:1脑高级别星形细胞瘤、脑转移瘤1 H-MRS与对侧相应正常区域对比均表现为Cho峰升高,NAA、Cr峰下降。12例胶质母细胞瘤中,显示Lip峰者11例。20例脑转移瘤中,11例见Lac峰升高,9例Lip峰升高。2高级别星形细胞瘤肿瘤实体区的Cho/NAA明显高于脑转移瘤(P0.05);高级别星形细胞瘤瘤周水肿的Cho/Cr、Cho/NAA明显高于脑转移瘤(P0.05)。结论:3.0T1 H-MRS分析对高级别星形细胞瘤、脑单发转移瘤的诊断和鉴别诊断有重要价值,可作为一种非损伤性的鉴别手段;肿瘤瘤周水肿带的波谱更有利于胶质瘤与转移瘤的鉴别。     

Proton MR spectroscopy of the brain in infants

Proton magnetic resonance spectroscopy (MRS) was used to study the brain of 2 normal and 15 abnormal infants aged from 33 weeks postmenstrual age (PMA) to 14 months postnatal age. Eleven of the infants were examined on at least two occasions. The principal clinical diagnoses in the abnormal infants were perinatal ischemic and hemorrhagic brain injury. All proton spectra demonstrated peaks that were assigned to N-acetylaspartate (NAA), choline containing compounds (Cho), and creatine plus phosphocreatine (Cr). The NAA/Cho and NAA/Cr ratios increased with age, while the Cho/Cr ratio decreased with age in the majority of infants. The NAA/Cho ratio was generally lower in abnormal infants, but the difference was not apparent before 40 weeks (PMA). This ratio was lowest in infants with the severest degree of neurological abnormality. Proton and phosphorus MRS was compared in seven infants. In those with severe brain lesions, early phosphorus spectra were abnormal. On follow-up the phosphorus spectra became normal, but the proton spectra showed persistently low NAA/Cho and NAA/Cr ratios. Proton MRS provides new information that may be complementary to phosphorus MRS in the diagnosis and monitoring of brain development in normal and neurologically damaged infants.     

Proton magnetic resonance spectroscopy of brain-stem lesions

The imaging findings of brain-stem lesions are often nonspecific and histological diagnosis is limited because of fear of complications associated with biopsy. A noninvasive method for tissue characterization is therefore highly desirable. We undertook a review of proton magnetic resonance spectroscopy (MRS) of patients with solitary brain-stem lesions to determine if MRS could characterize them. We carried out single- or multivoxel proton MRS using long echo times (135 or 270 ms) on 34 patients with solitary brain-stem lesions. We analyzed the following peaks: choline (Cho), creatine (Cr), N-acetylaspartate (NAA), and lipids/lactate (Lip) and calculated peak height ratios for Cho/Cr, NAA/Cr and Lip/Cr. The results were compared with histology in nine patients and with the presumptive diagnosis in 25. We also performed single-voxel proton MRS on the brain stem of five normal volunteers. There were differences in all ratios between controls and the patients with neoplastic and non-neoplastic lesions: Cho/Cr was low in non-neoplastic and high in neoplastic lesions (control: 1.8+/-0.1; non-neoplastic: 1.4+/-0.2; neoplastic: 2.0+/-0.2); NAA/Cr was low in non-neoplastic, and lower in neoplastic lesions (control: 2.3+/-0.1; non-neoplastic: 1.4+/-0.2; neoplastic: 1.2+/-0.1), and Lip/Cr was elevated in both neoplastic and non-neoplastic lesions (control: 0.04+/-0.02; nonneoplastic: 1.9+/-0.7; neoplastic:1.9+/-0.7).     

磁敏感加权成像及波谱成像在脑星形细胞瘤分级诊断中的价值研究

目的探讨磁敏感加权成像(SWI)及波谱成像(MRS)在脑高、低级别星形细胞瘤鉴别诊断中的价值。资料与方法搜集2009年12月至2011年1月37例经手术病理证实的星形细胞瘤患者的MRI资料,所有患者术前均应用Siemens Verio 3.0 T超导磁共振仪行常规MRI平扫+增强、SWI和2D1H-MRS,并将各自结果同病理结果比较并统计分析,得出敏感度、特异度并同常规MRI比较。结果 (1)SWI序列中显示星形细胞瘤的出血率在高、低级别星形细胞瘤鉴别诊断中无显著性差异(P>0.05),而出血量在高、低级别星形细胞瘤鉴别诊断中有显著性差异(P<0.05)。(2)高、低级别星形细胞瘤瘤体代谢物胆碱(Cho)/N-乙酰天门冬氨酸(NAA)、Cho/肌酸(Cr)、NAA/Cr均有显著性差异(P<0.05)。(3)瘤体出血指数C值和Cho/NAA联合筛检,敏感度100%,特异度83.3%。结论 (1)同常规MRI比较,SWI能提高星形细胞瘤分级诊断的特异度,2D1H-MRS能提高星形细胞瘤分级诊断的准确度。(2)瘤体出血指数C值和Cho/NAA值联合筛检能提高星形细胞瘤分级诊断的敏感度。     

Proton MR spectroscopic changes in Parkinson's diseases after thalamotomy

To investigate whether there are significant changes in regional brain metabolism in patients with Parkinson's disease before and after thalamotomy using proton magnetic resonance spectroscopy (1H MRS). Fifteen patients underwent 15 stereotactic thalamotomies for control of medically refractory parkinsonian tremor. Single-voxel 1H MRS was carried out on a 1.5 T unit using stimulated-echo acquisition mode (STEAM) sequence (TR/TM/TE, 2000/14/20 ms). Spectra were obtained from substantia nigra, thalamus and putamen areas with volumes of interests (7-8 ml) in patients before and after the surgery. Metabolite ratios of NAA/Cho, NAA/Cr and Cho/Cr were calculated from relative peak area measurements. We evaluated alterations of metabolite ratios in brain metabolism in Parkinson's disease patients with clinical outcome following thalamotomy. NAA/Cho ratios showed generally low levels in substantia nigra and thalamus in Parkinson's disease patients with clinical improvement following thalamotomy. In 80% (12/15) patients, decreased NAA/Cho ratios were observed from the selected voxels in substantia nigra after thalamic surgery (P<0.05). The ratios were also significantly decreased in thalamus in 67% (10/15) patients with clinical improvement (P<0.05). Our results suggest that NAA/Cho ratio may be a valuable criterion for evaluation of Parkinson's disease patients with the clinical improvement following surgery. 1H MRS may be a useful utility for the aid in better understanding the pathophysiologic process in Parkinson's disease patients on the basis of the variation of NAA/Cho ratio.     

Reproducibility of short echo time proton magnetic resonance spectroscopy using point-resolved spatially localized spectroscopy sequence in normal human brains.

The reproducibility of short echo time proton MR spectroscopy (1H-MRS) in normal human brains was examined. Thirteen healthy volunteers were studied, and each underwent three MRS examinations. Second and third measurements were done on the same day, about two months after the first measurement, and interday and intraday reproducibility were evaluated. MRS was performed with proton brain examination/single voxel (PROBE/SV) and point-resolved spatially localized spectroscopy (PRESS) (repetition time = 2000 ms, echo time = 30 ms). Five metabolite ratios were computed; N-acetyl-aspartate (NAA)/creatine (Cr), choline (Cho)/Cr, myo-inositol (mI)/Cr, NAA/(NAA + Cr + Cho), and NAA/Cho. Their normal range and reproducibility were measured. For each metabolite ratio, there was no significant difference between interday difference and intraday difference, suggesting that the interval of two months has minimal effect on MRS measurements. MRS may be utilized for the observation of central nervous system diseases.     

Evaluation of invasiveness of astrocytoma using <Superscript>1</Superscript>H-magnetic resonance spectroscopy: correlation with expression of matrix metalloproteinase-2

INTRODUCTION: Even low-grade astrocytomas infiltrate the entire brain, a feature that precludes their successful therapy. So to assess the invasive potential of astrocytoma is very important. The aim of this study was determine whether there is a significant correlation between the results of (1)H-magnetic resonance spectroscopy ((1)H-MRS) and tumor invasive potential of astrocytoma, which is reflected by expression of matrix metalloproteinase-2 (MMP-2). METHODS: The (1)H-MRS spectra of 41 histologically verified astrocytomas were obtained on a 3-T MR scanner. According to the World Health Organization classification criteria for central nervous system tumors, there were 16 low-grade astrocytomas (2 pilocytic astrocytomas, 14 grade II astrocytomas) and 25 high-grade astrocytomas (5 anaplastic astrocytomas, 20 glioblastomas).The choline/N-acetylaspartate (Cho/NAA) and choline/creatine (Cho/Cr) ratios were calculated. Of the 41 astrocytomas, 19 (8 low-grade and 11 high-grade) were analyzed immunohistochemically. Expression of MMP-2 was determined using streptavidin-peroxidase complex (SP) staining which was quantified by calculating its calibrated opacity density (COD) using an image analysis system. The correlations between metabolite ratios and the quantitative data from the immunohistochemical tests in the 19 astrocytomas were determined. RESULTS: The Cho/NAA and Cho/Cr ratios of high-grade astrocytoma were both significantly greater than those of low-grade astrocytoma (t = -6.222, P = 0.000; t = -6.533, P = 0.000, respectively). MMP-2 COD values of high-grade astrocytomas were also significantly greater than those of low-grade astrocytomas (t = -5.892, P = 0.000). There were strong positive correlations between Cho/NAA ratio and MMP-2 COD (r = 0.669, P = 0.002), and between Cho/Cr ratio and MMP-2 COD (r = 0.689, P = 0.001). CONCLUSION: (1)H-MRS is helpful in evaluating the invasiveness of astrocytomas and predicting prognosis preoperatively by determining the Cho/NAA and Cho/Cr ratios.     

Cerebral metabolic changes in delayed carbon monoxide sequelae studied by proton MR spectroscopy

The pathogenesis of delayed sequelae of carbon monoxide (CO) exposure is still unknown. We repeatedly examined a 55-year-old woman with the interval form of CO poisoning, using proton magnetic resonance spectroscopy (MRS). When the clinical picture was severe, MRS revealed markedly lowered N-acetyl-asparatate (NAA)/creatine and phosphocreatine (Cr) ratio and slightly increased choline containing compounds (Cho)/Cr ratio. Subsequently, NAA and Cho/Cr ratio tended to return to normal, reflecting clinical improvement. Proton MRS shows the previously unrecognised neuronal activity in CO poisoning and precisely reflects the severity of symptoms. We stress the superiority of proton MRS over the conventional radiological examinations in CO poisoning.     

磁共振质子波谱在颞叶癫痫诊断中的应用

目的　评价磁共振质子波谱 (1HMRS)诊断颞叶癫痫的价值。方法　对 30例颞叶癫痫患者和 30例健康志愿者用 2 0T场强的MR成像系统分别进行双侧颞叶的质子波谱采集 ,定量分析N 乙酰天门冬氨酸 (NAA)、肌酸 (Cr)和胆碱复合物 (Cho)等代谢产物的变化。结果　癫痫病人NAA峰降低。以NAA/ (Cr Cho)值为判断标准 ,2 5例病人可以定侧诊断 ,敏感性 83% ,并发现 14例双侧病变 ,占 47%。结论　1HMRS可无创性探测脑组织内生化改变 ,对癫痫灶的定侧诊断具有很高的价值     

Proton MR spectroscopy of intracranial tumours: in vivo and in vitro studies

Proton magnetic resonance spectroscopy (1H MRS) was used to investigate intracranial tumours in vitro and in vivo. Biopsy specimens were studied from 47 patients, 11 of whom were also examined in vivo. Analysis was based on the signals from N-acetylaspartate (NAA), phosphocreatine plus creatine (Cr), choline-containing compounds (Cho), alanine (Ala), and lactate. Biopsy data from 26 astrocytomas showed that the NAA/Cr ratio differs significantly in all grades from its value in normal white matter and that the Cho/Cr ratio differs significantly in grade IV tumours from its value in the other grades. Meningiomas have an unusually high Ala/Cr ratio. Spectra obtained in vivo are consistent with in vitro results from the same patients, and their lactate signal provides additional information about abnormal metabolism. We conclude that 1H MRS has a clear role in the diagnosis and biochemical assessment of intracranial tumours and in the evaluation and monitoring of therapy.     

Single voxel proton MR spectroscopy findings of typical and atypical intracranial meningiomas

PURPOSE: To prospectively define proton magnetic resonance spectroscopy (MRS) findings of meningiomas, and describe the ability or inability of short- and long-echo MRS to differentiate typical and atypical meningiomas in vivo. MATERIAL AND METHODS: Seventeen patients with pathologically confirmed typical meningiomas and six with atypical meningiomas were evaluated with conventional MR imaging and MRS before resection. MRS studies using point-resolved spectroscopy (PRESS) localisation, at short- and long-echo time (TR 2000 ms, TE: 30 and 144 ms, 64-96 acquisition) were acquired on a 1.5 T scanner. MRS data obtained from these patients were compared with histopathological findings. Mean cellular proliferation (MIB-1) antibody staining against the Ki-67 antigen was also determined in all meningiomas. RESULTS: Prominent choline (Cho) was present in all meningiomas. Alanine (Ala) was observed in 21 cases of the 23 meningiomas. Acetylaspartate (NAA) and creatine (Cr) were either not observed or detected in minimal amounts in at all both groups of meningiomas on long TE (144 ms) spectra. The mean Cho/Cr values in the four atypical meningiomas were 4.44+/-0.30 (mean+/-standard deviation) and 3.39+/-0.52 in the 12 typical meningiomas on short TE spectra. Cho/Cr ratio could not be determined in the other seven cases because of a lack of creatine peak. Of the five meningiomas in which a lactate peak was detected, four were in typical cases and only one was in atypical meningioma. Mean MIB-1 proliferation index was 3.7% in typical meningiomas and 10% in atypical meningiomas. CONCLUSION: Prominent Cho, absence or low amount of NAA and Cr, and presence of Ala were common characteristics of spectral pattern of both atypical and typical meningiomas on MRS. MRS cannot reliably differentiate typical intracranial meningiomas from atypical meningiomas preoperatively. Mean MIB-1 proliferation index was well correlated with histopathology findings.     

Proton magnetic resonance spectroscopy of late delayed radiation-induced injury of the brain.

We prospectively evaluated metabolite changes in late delayed radiation-induced injury to the temporal lobes on proton ((1)H) magnetic resonance spectroscopy (MRS) in 34 patients. Morphologically more severe injury on imaging tended to have lower N-acetyl aspartate (NAA)/creatine (Cr) and NAA/choline (Cho) ratios. A significantly higher Cho/Cr ratio was found in the most severe grade of cerebral necrosis, in which lactate might be present. The progressive decrease in NAA with increasing severity reflected neuronal loss at different stages of late delayed radiation-induced brain injury. The absence of Cho elevation in mild and moderate lesions did not suggest demyelination or glial hyperplasia as an etiologic mechanism of late delayed radiation-induced brain injury. The association of severe morphologic lesions with elevated lactate suggests ischemia as the underlying mechanism for severe lesions. (1)H MRS may provide metabolite information conducive to the understanding of the pathophysiology of late radiation-induced brain injury. J. Magn. Reson. Imaging 1999;10:130-137.     

Proton MR spectroscopy of pediatric cerebellar tumors.

PURPOSETo investigate the role of proton MR spectroscopy in pediatric cerebellar tumor diagnosis.METHODSSingle voxel pulse sequences with long echo time (135 or 270 milliseconds, voxel size 8 to 19 cm3), were used to obtain proton spectra of primary pediatric cerebellar tumors. Eleven primitive neuroectodermal tumors (patient age, 2 to 12 years; mean, 7 years), 11 low-grade astrocytomas (age, 2 to 16 years; mean, 9 years), 4 ependymomas (age, 1 to 6 years; mean, 4 years), 1 mixed glioma ependymo-astrocytoma (age, 11 years), 1 anaplastic ependymoma (age, 7 years), 1 ganglioglioma (age, 14 years), and 1 malignant teratoma (age, 6 days) were studied. Control cerebellum spectra were acquired from five patients without abnormality in cerebellum (age, 2 to 15 years; mean, 8 years). The signal intensities from choline-containing compounds (Cho), creatine/phosphocreatine (Cr), N-acetyl-aspartate (NAA), and lactate (Lac) were quantified. The mean and standard deviation of metabolite ratios were calculated.RESULTSThe control spectra ratios (NAA:Cho = 1.49 +/- 0.36, Cr:Cho = 1.13 +/- 0.23) were distinct from the tumor spectra (NAA:Cho = 0.41 +/- 0.27 and Cr:Cho = 0.37 +/- 0.23). Most of primitive neuroectodermal tumors had low NAA:Cho (0.17 +/- 0.09) and Cr:Cho (0.32 +/- 0.19). Compared with primitive neuroectodermal tumors, low-grade astrocytomas and ependymomas had higher NAA:Cho ratio (0.63 +/- 0.19 and 0.39 +/- 0.12). The Cr:Cho ratio was higher for ependymomas (0.60 +/- 0.20) than for astrocytomas (0.27 +/- 0.12) and primitive neuroectodermal tumors. No NAA was found in the malignant teratoma. Lac:Cho ratio was 0.66 +/- 0.40, 0.58 +/- 0.30, and 0.08 +/- 0.12 for astrocytoma, ependymoma, and primitive neuroectodermal tumor, respectively. Lactate was elevated in the mixed glioma ependymo-astrocytoma, ganglioglioma, and teratoma. The NAA and lactate signals were sometimes obscured by lipids in the spectra. Discriminant analysis was carried out using NAA:Cho and Cr:Cho ratios to differentiate the three major tumor types. The sensitivity/specificity values for diagnosing astrocytoma, ependymoma, and primitive neuroectodermal tumor were found to be 0.91/0.84, 0.75/0.92, and 0.82/0.89, respectively, based on this study.CONCLUSIONIn many cases, proton MR spectroscopy can be used to help differentiate cerebellar primitive neuroectodermal tumor, low-grade astrocytoma, and ependymoma.     

Magnetic resonance imaging and spectroscopy of pilomyxoid astrocytomas: case reports and comparison with pilocytic astrocytomas

BACKGROUND AND PURPOSE: Pilomyxoid astrocytomas (PMAs) have been described only recently. They appear as low-grade tumors sharing imaging features similar to pilocytic astrocytomas (PAs). However, pilomyxoid astrocytomas have different histological features and behave more aggressively than PAs. We present the imaging and proton spectroscopic (magnetic resonance spectroscopy; MRS) findings in 3 patients with PMA and compare them with those of PA arising in other sites. METHODS: Three patients who later proved to harbor PMA were studied with MR imaging and multivolume MRS. We analyzed the imaging findings, with attention to location, size, signal intensities, pattern of enhancement, and edema. In addition, we analyzed the MRS, with attention to the peaks of choline (Cho), creatine (Cr), N-acetyl aspartate, lipids, lactate, and myoinositol, and ratios between these metabolites. We compared the MRS studies of PMA with those of PA located in the hypothalamus and brain stem. RESULTS: In 2 patients, the PMAs were located in the chiasmatic-hypothalamic and third-ventricular-hypothalamic regions, showing solid enhancement, high T2 signal intensity, and hydrocephalus. One PMA was found in the right parietal lobe showing a well-defined mass without enhancement and high T2 signal intensity. The 2 PMAs showed high Cho/Cr ratios in peritumoral regions at long echo time in comparison with PA. A third PMA showed slight elevation of Cho/Cr ratio in peritumoral regions and no elevation of Cho/Cr ratios within the mass when compared with a PA. Short echo time MRS obtained in 2 PMAs showed low myoinositol/Cr ratios in tumoral regions in comparison with PA. CONCLUSIONS: Our 2 PMAs showed imaging features similar to those described in the literature. Magnetic resonance spectroscopy showed elevated Cho/Cr outside their enhancing margins, which may be related to their more aggressive behavior when compared with PA. The third PMA was different to those previously reported in the literature because it was hemispheric rather than hypothalamic in location in addition to having low intratumoral ratios of Cho/Cr.     

海马硬化MR质子波谱分析与MRI的对比研究

目的　评价MR质子波谱分析 (1HMRS)和MRI对海马硬化的诊断价值。方法　对 8例病理证实的海马硬化病人和 8例健康志愿者分别进行1HMRS和MRI海马体积定量研究。通过计算峰下面积 ,对代谢产物氮 乙酰天门冬氨酸 (NAA)、肌酸 (Cr)及胆碱复合物 (Cho)的浓度进行定量并观察NAA/Cr、NAA/ (Cr Cho)及Cho/Cr各参数的变化 ,同时用右侧海马体积和左侧海马体积差值(DHF)的方法分析形态学的异常。结果　病变组病侧NAA/Cr、NAA/ (Cr Cho)及Cho/Cr值分别为0 5 5、1 77及 1 38,对照组分别为 0 77、1 38及 1 0 6。海马硬化病人NAA/Cr和NAA/ (Cr Cho)值下降 ,统计学上差异有显著性意义 (t值分别为 2 15和 4 83,P值均 <0 0 5 ) ,Cho/Cr值升高 ,统计学上差异有显著性意义 (t值为 2 34 ,P <0 0 5 )。根据NAA/ (Cr Cho)值的不对称降低可对 6例病人进行定侧诊断 ,其中错误 1例 ;根据DHF值的变化可诊断海马萎缩 2例。所有病例均经手术病理证实为海马硬化 ,病变程度与NAA/ (Cr Cho)值的降低相一致。NAA/ (Cr Cho)减低与癫痫发作次数无相关性 (r=- 0 134 ,P >0 0 5 )。结论　1HMRS能够早期发现海马硬化。1HMRS和MRI互相补充有利于海马硬化的术前诊断。     

Diagnostic potential of short echo time MR spectroscopy of gliomas with single-voxel and point-resolved spatially localised proton spectroscopy of brain

Accurate neuroimaging grading of gliomas is useful for management, but techniques such as MRI and CT are not sufficiently reliable. Necrosis is a consistent, decisive prognostic factor and the key diagnostic criterion for glioblastoma multiforme. MR spectroscopy (MRS) allows noninvasive measurement of metabolites in brain tumours and mobile lipids reflect necrosis. However, short echo-time (TE) spectroscopy has been required for reliable assessment of lipids, since their relaxation times are very short. Recent advances have made it possible to perform short-TE MRS. We attempted to evaluate the significance of short TE spectroscopy as part of routine imaging for diagnosis and grading of gliomas. We performed TE 30 ms MRS in 25 patients with gliomas (grade II six; grade III three; grade IV, 16) and in 19 areas of healthy white matter using proton brain examination/single voxel (PROBE/SV) and point-resolved spatially localised spectroscopy (PRESS). With short-TE spectroscopy, lipid signals were detected in all 16 tumours of grade IV, one grade II (P = 0.0002) and none of grade III (P = 0.001). TE 136 ms MRS, carried out in 20 of these cases, showed lipid signals in only four of 14 grade IV tumours and in none of the other six. N-acetylaspartate/choline (NAA/Cho) ratios were always more than 1.0 in healthy tissues and less than 1.0 in all but one of the gliomas. The mean creatine (Cr)/Cho ratio in each tumour grade was significantly lower than in the healthy tissues. The mean Cr/Cho ratio was also significantly lower in grade IV than in grade II tumours (P < .0005). Considerable overlap in Cr/Cho ratio was observed between grade II and grades III and IV gliomas at long but less so at short-TE MRS. We conclude that short-TE MRS with PROBE/SV and PRESS is of value in grading gliomas. Received: 25 June 2000 Accepted: 1 September 2000     

儿童神经元蜡样质脂褐素沉积病的MRI及MRS表现

目的：分析婴儿型和晚期婴儿型神经元蜡样质脂褐素沉积病（NCL）的MRI、磁共振波谱（^1H—MRS）表现。方法：对2例婴儿型和8例晚期婴儿型NCL患儿行磁共振平扫和磁共振波谱检查。总结分析各种特征性影像表现及N-乙酰天门冬氨酸（NAA）、总肌酸（Cr）、胆碱复合物（Cho）、NAA／Or、Cho／Cr比值的变化规律。结果：10例患儿都表现为逐渐进展的脑萎缩,婴儿型以大脑萎缩为早期表现,晚期婴儿型以小脑萎缩为早期表现。2例婴儿型病例及病史4～5年的晚期婴儿型患儿可见大脑半球白质的异常高信号,脑室旁白质最为明显。婴儿型病例见双侧丘脑和基底节核团T2WI低信号。8例发现颅骨板障明显增厚。磁共振波谱显示随着病程延长,晚期婴儿型病例的NAA／Cr比值逐渐降低,Cho／Cr值未见明显变化。婴儿型病例末观测到NAA峰,Cho／Cr水平降低,肌醇（mi）水平明显增高。结论：MRI和^1H—MRS可以敏感地发现婴儿型和晚期婴儿型患儿脑内的异常改变9有助于NCL的诊断和分型,并可以评价疾病的严重程度,监测病情变化。